- Home
- PRGO
PRGO
Perrigo Company plc
as 07-26-2024 4:00pm EST
Upcoming Earnings Alert:
Get ready for potential market movements as Perrigo Company plc PRGO prepares to release earnings report on 02 Aug 2024.
| Founded: | 1887 | Country: | Ireland |
| Employees: | N/A | City: | DUBLIN 2 |
| Market Cap: | N/A | IPO Year: | 1991 |
| Target Price: | $39.33 | AVG Volume (30 days): | 1.4M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | -0.06 | EPS Growth: | N/A |
| 52 Week Low/High: | $24.82 - $40.28 | Next Earning Date: | 08-02-2024 |
| Revenue: | $4,555,900,000 | Revenue Growth: | -0.07% |
| Revenue Growth (this year): | 1.21% | Revenue Growth (next year): | 4.54% |
Stock Insider Trading Activity of Perrigo Company plc (PRGO)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Andersen Svend | PRGO | EVP & President CHCI | May 28 '24 | Buy | $27.90 | 1,000 | $27,900.00 | 101,853 | SEC Form 4 |
| Ives Alison | PRGO | EVP & Chief Scientific Officer | Mar 5 '24 | Buy | $27.26 | 2,490 | $67,877.40 | 16,122 | SEC Form 4 |
| Ives Alison | PRGO | EVP & Chief Scientific Officer | Feb 29 '24 | Buy | $26.44 | 1,545 | $40,849.80 | 12,446 | SEC Form 4 |
| Willis Robert | PRGO | EVP & CHRO | Feb 29 '24 | Buy | $25.87 | 6,000 | $155,220.00 | 25,105 | SEC Form 4 |
| Willis Robert | PRGO | EVP & CHRO | Feb 29 '24 | Buy | $26.30 | 371 | $9,757.30 | 25,476 | SEC Form 4 |
| Lockwood-Taylor Patrick | PRGO | CEO | Feb 29 '24 | Buy | $26.54 | 9,500 | $252,168.00 | 20,500 | SEC Form 4 |
| Willis Robert | PRGO | EVP & CHRO | Nov 24 '23 | Buy | $31.01 | 5,550 | $172,105.50 | 19,105 | SEC Form 4 |
| Ives Alison | PRGO | EVP & Chief Scientific Officer | Nov 16 '23 | Buy | $29.34 | 2,040 | $59,853.60 | 10,901 | SEC Form 4 |
| Lockwood-Taylor Patrick | PRGO | CEO | Nov 14 '23 | Buy | $28.99 | 11,000 | $318,868.00 | 11,000 | SEC Form 4 |
| Bezerra Eduardo Guarita | PRGO | EVP & Chief Financial Officer | Nov 14 '23 | Buy | $29.18 | 5,000 | $145,881.50 | 8,428 | SEC Form 4 |
Latest Perrigo Company plc News
PRGO Breaking Stock News: Dive into PRGO Ticker-Specific Updates for Smart Investing
Zacks
10 hours ago
Analysts Estimate Perrigo (PRGO) to Report a Decline in Earnings: What to Look Out for
Insider Monkey
4 days ago
Does Perrigo (PRGO) Have a Good Growth Potential?
PR Newswire
7 days ago
Perrigo to Release Second Quarter 2024 Financial Results on August 2, 2024
MT Newswires
15 days ago
Piper Sandler Trims Price Target on Perrigo to $35 From $36, Maintains Overweight Rating
MT Newswires
16 days ago
Perrigo Divests HRA Pharma Rare Diseases Business to Esteve Healthcare
PR Newswire
17 days ago
Perrigo Completes Divestment of HRA Pharma Rare Diseases Business
Argus Research
a month ago
Analyst Report: Perrigo Company PLC
Argus Research
a month ago
Market Update: CHD, PRGO, LIN
Compare PRGO vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PRGO Perrigo Company plc - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.